Knockdown of glucose-6-phosphate dehydrogenase (G6PD) following cerebral ischemic reperfusion: the pros and cons

Neurochemistry International
Gang ZhaoYing Xu

Abstract

NADPH derived from glucose-6-phosphate dehydrogenase (G6PD), the rate-limiting enzyme of the pentose phosphate pathway, has been implicated not only to promote reduced glutathione (GSH) but also enhance oxidative stress in specific cellular conditions. In this study, the effects of G6PD antisense oligodeoxynucleotides (AS-ODNs) was examined on the CA1 pyramidal neurons following transient cerebral ischemia. Specifically knockdown of G6PD protein expression in hippocampus CA1 subregion at early reperfusion period (1-24 h) with a strategy to pre-treated G6PD AS-ODNs significantly reduced G6PD activity and NADPH level, an effect correlated with attenuation of NADPH oxidase activation and superoxide anion production. Concomitantly, pre-treatment of G6PD AS-ODNs markedly reduced oxidative DNA damage and the delayed neuronal cell death in rat hippocampal CA1 region induced by global cerebral ischemia. By contrast, knockdown of G6PD protein at late reperfusion period (48-96 h) increased oxidative DNA damage and exacerbated the ischemia-induced neuronal cell death in hippocampal CA1 region, an effect associated with reduced NADPH level and GSH/GSSG ratio. These findings indicate that G6PD not only plays a role in oxidative neuronal dam...Continue Reading

References

May 1, 1979·Stroke; a Journal of Cerebral Circulation·W A Pulsinelli, J B Brierley
May 1, 1982·Annals of Neurology·W A PulsinelliF Plum
Aug 1, 1995·Stroke; a Journal of Cerebral Circulation·K AbeY Itoyama
Oct 7, 1998·Progress in Neurobiology·G StollM Schroeter
Jan 10, 2001·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·P H Chan
Aug 27, 2002·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Carolina M Maier, Pak H Chan
Sep 16, 2003·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Masaki NishimuraEisuke Nishida
Oct 4, 2003·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Takeshi HayashiPak H Chan
Mar 31, 2004·Cellular and Molecular Life Sciences : CMLS·M Arundine, M Tymianski
Jun 13, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Hua HongAlex F Chen
Jul 11, 2006·Journal of Molecular and Cellular Cardiology·Sachin A GupteFabio A Recchia
Feb 3, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Andrey Y AbramovMichael R Duchen
Mar 27, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Mohanraj RajeshPál Pacher
Aug 19, 2007·The Journal of International Medical Research·L L TangJ S Zheng
Nov 5, 2008·The Journal of Pharmacology and Experimental Therapeutics·Sharanya VemulaThomas J Abbruscato
Dec 25, 2008·Annals of Neurology·Sang Won SuhRaymond A Swanson
May 7, 2009·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Hai ChenPak H Chan
Apr 7, 2010·The Journal of Biological Chemistry·Rakhee S GupteSachin A Gupte
Sep 23, 2010·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Hideyuki YoshiokaPak H Chan
Jan 5, 2011·Frontiers in Bioscience (Landmark Edition)·Sophocles ChrissobolisChristopher G Sobey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Stroke

A stroke occurs when blood supply to the brain is interrupted depriving the brain of oxygen and nutrients. This feed focuses cerebrovascular accidents including ischemic and paralytic stroke.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Angelman Syndrome

Angelman syndrome is a neurogenetic imprinting disorder caused by loss of the maternally inherited UBE3A gene and is characterized by generalized epilepsy, limited expressive speech, sleep dysfunction, and movement disorders. Here is the latest research.

Related Papers

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
Barry J ConnellTarek M Saleh
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
Hideyuki YoshiokaPak H Chan
© 2021 Meta ULC. All rights reserved